All treatments
Treatment
VALSARTAN AND SACUBITRIL clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase III and phase IV (Integrated)
Initiation of angiotensin receptor-neprilysin inhibitor (ARNi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF): the INITIATE-HFrEF randomized open-label trial
This study is looking at new ways to treat heart failure where the heart struggles to pump blood effectively. It compares different combinations of existing medicines to see which approach works best and is safest for patients over a six-month period.
For: Heart failure with reduced ejection fractionPortugal - Ongoing, recruitingTherapeutic exploratory (Phase II)
A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure
This study is looking into a new medication called XXB750 for people with heart failure. It hopes to see how well it works, what dose is best, and if it's safe compared to a dummy treatment or existing medicines.
For: Heart FailureNetherlands · Italy · Bulgaria